Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus intra-arterial heparin for prevention of radial artery occlusion during transradial coronary angiography
IRCT20220724055544N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-blind trial of heparin in Radial artery occlusion (RAO) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Prothrombin time, Partial thromboplastin time and 5 more. Started Nov 2022; status: completed.
02
Drugs
heparin
03
Conditions
Radial artery occlusion (RAO)
Beyond the preview
Go deeper on IRCT20220724055544N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220724055544N1.